Last reviewed · How we verify

NCT05329948: Haptonomy

Application of Haptonomy and Pregnancy Adjustment, Paternal Attachment

Completed NA Last updated 6 July 2023
What this trial tests

NA trial testing Haptonomy application in Father-Child Relations in 286 participants. Completed in 5 April 2023.

Timeline
5 April 2022
Primary endpoint
5 April 2022
5 April 2023

Quick facts

Lead sponsorAtaturk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment286
Start date5 April 2022
Primary completion5 April 2022
Estimated completion5 April 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

Eligibility, any sex, with Father-Child Relations. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The pregnancy process is experienced not only by the mother, but also by the fathers, so it is thought that the application of haptonomy, which is the science of love, communication and feeling together, will confirm the emotional existence of the baby in the prenatal period, and support the attachment of the father and the adaptation of the mothers to pregnancy. Therefore, this study; It was aimed to evaluate the effect of haptonomy application on prenatal attachment of fathers and compliance with pregnancy and to contribute to the midwifery literature of the results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Father-Child Relations

Currently open trials in the same condition.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05329948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing